Sensorium Therapeutics: Funding, Investors & Team (Sep 2026)
The biotechnology company Sensorium Therapeutics was founded by eminent scientists, doctors, and thought leaders from Massachusetts General Hospital and Harvard University. It uses cutting-edge chemistry, neuroscience, and machine learning to create naturally derived psychoactive medicines for mental health. Sensorium's revolutionary Biodynamic Discovery Platform uses cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can provide transformative benefits to patients all over the world. This platform was inspired by the real-world human benefits of plants and fungi. To find out more, go to sensoriumbio.
Sensorium Therapeutics has raised $45.5M across 2 funding rounds on record, the most recent a Series A of $30.0M announced in Nov 2022.
That round is above the $3.0M median round size for Biotechnology Research companies tracked on FundedIQ over the last two years.
Sensorium Therapeutics Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Sensorium Therapeutics Funding Rounds
Sensorium Therapeutics raised $15.5M in an undisclosed round announced in Oct 2022.
1 month later, a Series A of $30.0M was announced in Nov 2022.
Sensorium Therapeutics Founders and Leadership Team
Contact details for the Sensorium Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Sensorium Therapeutics Funding Compared to Other Biotechnology Research Startups
Sensorium Therapeutics' latest round of $30.0M is above the median round in Biotechnology Research. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sensorium Therapeutics in Biotechnology Research and Boston
Companies Similar to Sensorium Therapeutics
FibroBiologics is a regenerative medicine firm situated in Houston, Texas that is working on an inventive…
FoamLab specializes in high-performance, bio-based foams made from bacterial nanocellulose and develops a new…
Intrinsic Foundries is pioneering carbon capture and utilization technology that converts industrial waste…
Auxilium Biotechnologies specializes in developing technology for repairing peripheral nerves.
Expedition Medicine's industry-leading chemoproteomics data generating engine learns the rules of molecular…
Avidicure is leading the way in developing a new type of antibody treatment called "AVC-Boosters", which have…
Orange Grove Bio (OGB) is a platform that specializes in investing and developing preclinical drugs, with the…
The Verschuren Centre assists in the advancement of sustainable technologies for cleantech companies and…
A new class of programmable polymer nanoparticles is being developed by Nanite, a next-generation non-viral…
a nonprofit organisation dedicated to reducing greenhouse gas emissions by genetically increasing CO2…
Love Lifesciences is creating a line of injection safety tools that will enhance patient comfort when…
Empatica is a startup that specializes in emotional computing and human data analytics. We create…
Sensorium Therapeutics Funding FAQs
What does Sensorium Therapeutics do?
The biotechnology company Sensorium Therapeutics was founded by eminent scientists, doctors, and thought leaders from Massachusetts General Hospital and Harvard University. It uses cutting-edge chemistry, neuroscience, and machine learning to create naturally derived psychoactive medicines for mental health. Sensorium's revolutionary Biodynamic Discovery Platform uses cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can provide transformative benefits to patients all over the world. This platform was inspired by the real-world human benefits of plants and fungi. To find out more, go to sensoriumbio.
How much funding has Sensorium Therapeutics raised?
Sensorium Therapeutics has raised $45.5M across 2 rounds on record. The most recent is a Series A of $30.0M announced in Nov 2022.
When did Sensorium Therapeutics last raise funding?
Sensorium Therapeutics' most recent funding round on record is a Series A of $30.0M, announced in Nov 2022.
Who is the CEO of Sensorium Therapeutics?
Dick Simon is listed as CEO at Sensorium Therapeutics.
Where is Sensorium Therapeutics headquartered?
Sensorium Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Sensorium Therapeutics have?
Sensorium Therapeutics is in the 11-50 employee band.
How does Sensorium Therapeutics' funding compare to other Biotechnology Research startups?
Sensorium Therapeutics' latest round of $30.0M is above the $3.0M median round size for Biotechnology Research companies on FundedIQ across 24 tracked companies over the last two years.
About FundedIQ's Sensorium Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sensorium Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.